A kernel for open source drug discovery in tropical diseases

PLoS Neglected Tropical Diseases

Volumn 3, Issue 4, 2009, Pages

  Orti, Leticia ^a   Carbajo, Rodrigo J ^a   Pieper, Ursula ^b   Eswar, Narayanan ^b,c   Maurer, Stephen M ^d   Rai, Arti K ^e   Taylor, Ginger ^f   Todd, Matthew H ^g   Pineda Lucena, Antonio ^a   Sali, Andrej ^b   Marti Renom, Marc A ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUPONT COMPANY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e DUKE UNIVERSITY   (United States)

^f The Synaptic Leap   (United States)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRIMETHOPRIM; VORINOSTAT; ZIDOVUDINE; ANTIPARASITIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; KERNEL METHOD; MATHEMATICAL COMPUTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN DATABASE; PROTEIN STRUCTURE; TROPICAL DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; DRUG DEVELOPMENT; HUMAN; METHODOLOGY; TROPICAL MEDICINE;

ANTIPARASITIC AGENTS; COMPUTER SIMULATION; DRUG DISCOVERY; HUMANS; MODELS, MOLECULAR; SOFTWARE; TROPICAL MEDICINE;

EID: 65549129121     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000418     Document Type: Article

References (63)

1. Nwaka S, Ridley RG (2003) Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov 2: 919-928.
2. Rai A, Reichman JR, Uhlir P, Crossman C (2008) Pathways across the valley of death: novel intellectual property strategies for accelerating drug discovery. Yale J Health Policy Law Ethics 8: 53-89.
3. Baker D, Sali A (2001) Protein structure prediction and structural genomics. Science 294: 93-96.
4. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325.
5. Kopp J, Schwede T (2006) The SWISS-MODEL Repository: new features and functionalities. Nucleic Acids Res 34: D315-D318.
6. Pieper U, Eswar N, Davis FP, Braberg H, Madhusudhan MS, et al. (2006) MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res 34: D291-D295.
7. Tramontano A (2006) The role of molecular modelling in biomedical research. FEBS Lett 580: 2928-2934.
8. Aguero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, et al. (2008) Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov 7: 900-907.
9. Marti-Renom MA, Rossi A, Al-Shahrour F, Davis FP, Pieper U, et al. (2007) The AnnoLite and AnnoLyze programs for comparative annotation of protein structures. BMC Bioinformatics 8: S4.
10. Watson JD, Sanderson S, Ezersky A, Savchenko A, Edwards A, et al. (2007) Towards fully automated structure-based function prediction in structural genomics: a case study. J Mol Biol 367: 1511-1522.
11. Rester U (2008) From virtuality to reality-virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. Curr Opin Drug Discov Devel 11: 559-568.
12. Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semiempirical free energy force field with charge-based desolvation. J Comput Chem 28: 1145-1152.
13. Leach AR, Shoichet BK, Peishoff CE (2006) Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J Med Chem 49: 5851-5855.
14. Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303: 1800-1805.
15. de Paulis T (2007) Drug evaluation: PRX-00023, a selective 5-HT1A receptor agonist for depression. Curr Opin Investig Drugs 8: 78-86.
16. Maurer SM, Rai A, Sali A (2004) Finding cures for tropical diseases: is open source an answer? PLoS Med 1: e56. doi:10.1371/journal.pmed.0010056.
17. Munos B (2006) Can open-source R&D reinvigorate drug research? Nat Rev Drug Discov 5: 723-729.
18. Hopkins AL, Witty MJ, Nwaka S (2007) Mission possible. Nature 449: 166-169.
19. Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5: 941-955.
20. Nwaka S (2005) Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines. Trans R Soc Trop Med Hyg 99: S20-S29.
21. Nwaka S, Riopel L, Ubben D, Craft JC (2004) Medicines for Malaria Venture new developments in antimalarials. Travel Med Infect Dis 2: 161-170.
22. Kepler T, Marti-Renom MA, Maurer SM, Rai AK, Taylor G, et al. (2006) Open source research-the power of us. Aust J Chem 59: 291-294.
23. Sachs J (1999) Helping the world's poorest. Economist 352(8132): 17-20.
24. Kremer M, Glennerster R (2004) Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton: Princeton University Press.
25. Singh S (2008) India takes an open source approach to drug discovery. Cell 133: 201-203.
26. Matter A, Keller TH (2008) Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions. Drug Discov Today 13: 347-352.
27. Eswar N, John B, Mirkovic N, Fiser A, Ilyin VA, et al. (2003) Tools for comparative protein structure modeling and analysis. Nucleic Acids Res 31: 3375-3380.
28. Heiges M, Wang H, Robinson E, Aurrecoechea C, Gao X, et al. (2006) CryptoDB: a Cryptosporidium bioinformatics resource update. Nucleic Acids Res 34: D419-D422.
29. Hertz-Fowler C, Peacock CS, Wood V, Aslett M, Kerhornou A, et al. (2004) GeneDB: a resource for prokaryotic and eukaryotic organisms. Nucleic Acids Res 32: D339-D343.
30. Chen F, Mackey AJ, Stoeckert CJ Jr, Roos DS (2006) OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res 34: D363-D368.
31. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
32. Stoeckert CJ Jr, Fischer S, Kissinger JC, Heiges M, Aurrecoechea C, et al. (2006) PlasmoDB v5: new looks, new genomes. Trends Parasitol 22: 543-546.
33. Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, et al. (2008) ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res 36: D553-D556.
34. Wu CH, Apweiler R, Bairoch A, Natale DA, Barker WC, et al. (2006) The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res 34: D187-D191.
35. Marti-Renom MA, Pieper U, Madhusudhan MS, Rossi A, Eswar N, et al. (2007) DBAli tools: mining the protein structure space. Nucleic Acids Res 35: W393-W397.
36. Stuart AC, Ilyin VA, Sali A (2002) LigBase: a database of families of aligned ligand binding sites in known protein sequences and structures. Bioinformatics 18: 200-201.
37. Golovin A, Dimitropoulos D, Oldfield T, Rachedi A, Henrick K (2005) MSDsite: a database search and retrieval system for the analysis and viewing of bound ligands and active sites. Proteins 58: 190-199.
38. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901-D906.
39. Eswar N, Webb B, Pieper U, Shen M-Y, Eramian D, et al. (2008) ModPipe: a large-scale protein structure modeling pipeline for the genomic era. Submitted.
40. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
41. Smith TF, Waterman MS (1981) Identification of common molecular subsequences. J Mol Biol 147: 195-197.
42. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
43. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5.6.
44. Marti-Renom MA, Madhusudhan MS, Sali A (2004) Alignment of protein sequences by their profiles. Protein Sci 13: 1071-1087.
45. Shen MY, Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15: 2507-2524.
46. Eramian D, Shen MY, Devos D, Melo F, Sali A, et al. (2006) A composite score for predicting errors in protein structure models. Protein Sci 15: 1653-1666.
47. Melo F, Sanchez R, Sali A (2002) Statistical potentials for fold assessment. Protein Sci 11: 430-448.
48. Csizmadia F (2000) JChem: Java applets and modules supporting chemical database handling from web browsers. J Chem Inf Comput Sci 40: 323-324.
49. Weininger D, Weininger A, Weininger JL (1989) SMILES. 2. algorithm for generation of uniques SMILES notation. J Chem Inf Comput Sci 29: 97-101.
50. Gower JC (1971) A general coefficient of similarity and some of its properties. Biometrics 27: 857-871.
51. Dalvit C, Pevarello P, Tato M, Veronesi M, Vulpetti A, et al. (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 18: 65-68.
52. Meyer B, Peters T (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed 42: 864-890.
53. Creative Commons (last accessed February 2009) Protocol for implementing open access data. http://sciencecommons.org/projects/publishing/ open-access-data-protocol/.
54. Dybas JM, Madrid-Aliste CJ, Che FY, Nieves E, Rykunov D, et al. (2008) Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. PLoS ONE 3: e3899. doi:10.1371/ journal.pone.0003899.
55. Vissa VD, Brennan PJ (2001) The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol 2: REVIEWS1023.
56. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, et al. (2005) The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309: 409-415.
57. Rosowsky A, Papoulis AT, Forsch RA, Queener SF (1999) Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim. J Med Chem 42: 1007-1017.
58. Darkin-Rattray SJ, Gurnett AM, Myers RW, Dulski PM, Crumley TM, et al. (1996) Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci U S A 93: 13143-13147.
59. Mai A, Cerbara I, Valente S, Massa S, Walker LA, et al. (2004) Antimalarial and antileishmanial activities of aroyl-pyrrolyl-hydroxyamides, a new class of histone deacetylase inhibitors. Antimicrob Agents Chemother 48: 1435-1436.
60. Kan8deel M, Kitade Y (2008) Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase. J Biochem 144: 245-250.
61. Boettinger S, Burk DL (2004) Open source patenting. J Int Biotechnol Law 1: 221-231.
62. Feldman RC (2004) The open source biotechnology movement: is it patent misuse? Minn J Law Sci Technol 6: 117-166.
63. Maurer SM (2008) Open source drug discovery: finding a niche (or maybe several). UMKC Law Rev 76: 405-435.